The Explorer page allows for side-by-side comparisons of the clinical trial landscape, publication history or stock performance history based on indication or text terms. The figure above highlights the shift in clinical trial focus from cardiovascular disease to oncology over the past 20 years by comparing the percentage of active Phase 2 and Phase 3 industry-sponsored drug trials for these therapeutic areas by year.